Role of gut pathogens in development of irritable bowel syndrome

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Acute infectious gastroenteritis is one of the most commonly identifiable risk factors for the development of irritable bowel syndrome (IBS). A number of bacterial, viral and parasitic pathogens have been found to be associated with the development of IBS and other functional gastrointestinal (GI) disorders. Epidemiological studies have identified demographic and acute enteritis-related risk factors for the development of post-infectious-IBS (PI-IBS). Immune dysregulation, alterations in barrier function, serotonergic and mast cell activation have been identified as potential pathophysiological mechanisms. Additionally, variations in host genes involved in barrier function, antigen presentation and cytokine response have been associated with PI-IBS development. However, it is unknown whether specific pathogens have unique effects on long-term alterations in gut physiology or different pathogens converge to cause common alterations resulting in similar phenotype. The role of microbial virulence and pathogenicity factors in development of PI-IBS is also largely unknown. Additionally, alterations in host gut sensation, motility, secretion, and barrier function in PI-IBS need to be elucidated. Finally, both GI infections and antibiotics used to treat these infections can cause long-term alterations in host commensal microbiota. It is plausible that alteration in the commensal microbiome persists in a subset of patients predisposing them to develop PI-IBS.

Original languageEnglish (US)
Pages (from-to)11-18
Number of pages8
JournalIndian Journal of Medical Research
Volume139
StatePublished - Jan 2014

Fingerprint

Irritable Bowel Syndrome
Pathogens
Microbiota
Virulence Factors
Enteritis
Gastrointestinal Diseases
Physiology
Antigen Presentation
Gastroenteritis
Infection
Mast Cells
Epidemiologic Studies
Genes
Chemical activation
Demography
Cytokines
Anti-Bacterial Agents
Phenotype
Antigens

Keywords

  • Campylobacter jejuni
  • Functional GI disorders
  • Infectious gastroenteritis
  • Post-infectious irritable bowel syndrome
  • Rritable bowel syndrome

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Role of gut pathogens in development of irritable bowel syndrome. / Grover, Madhusudan.

In: Indian Journal of Medical Research, Vol. 139, 01.2014, p. 11-18.

Research output: Contribution to journalReview article

@article{6d50a8ea49b94a71a903d8bdb54aaee5,
title = "Role of gut pathogens in development of irritable bowel syndrome",
abstract = "Acute infectious gastroenteritis is one of the most commonly identifiable risk factors for the development of irritable bowel syndrome (IBS). A number of bacterial, viral and parasitic pathogens have been found to be associated with the development of IBS and other functional gastrointestinal (GI) disorders. Epidemiological studies have identified demographic and acute enteritis-related risk factors for the development of post-infectious-IBS (PI-IBS). Immune dysregulation, alterations in barrier function, serotonergic and mast cell activation have been identified as potential pathophysiological mechanisms. Additionally, variations in host genes involved in barrier function, antigen presentation and cytokine response have been associated with PI-IBS development. However, it is unknown whether specific pathogens have unique effects on long-term alterations in gut physiology or different pathogens converge to cause common alterations resulting in similar phenotype. The role of microbial virulence and pathogenicity factors in development of PI-IBS is also largely unknown. Additionally, alterations in host gut sensation, motility, secretion, and barrier function in PI-IBS need to be elucidated. Finally, both GI infections and antibiotics used to treat these infections can cause long-term alterations in host commensal microbiota. It is plausible that alteration in the commensal microbiome persists in a subset of patients predisposing them to develop PI-IBS.",
keywords = "Campylobacter jejuni, Functional GI disorders, Infectious gastroenteritis, Post-infectious irritable bowel syndrome, Rritable bowel syndrome",
author = "Madhusudan Grover",
year = "2014",
month = "1",
language = "English (US)",
volume = "139",
pages = "11--18",
journal = "Indian Journal of Medical Research",
issn = "0971-5916",
publisher = "Indian Council of Medical Research",

}

TY - JOUR

T1 - Role of gut pathogens in development of irritable bowel syndrome

AU - Grover, Madhusudan

PY - 2014/1

Y1 - 2014/1

N2 - Acute infectious gastroenteritis is one of the most commonly identifiable risk factors for the development of irritable bowel syndrome (IBS). A number of bacterial, viral and parasitic pathogens have been found to be associated with the development of IBS and other functional gastrointestinal (GI) disorders. Epidemiological studies have identified demographic and acute enteritis-related risk factors for the development of post-infectious-IBS (PI-IBS). Immune dysregulation, alterations in barrier function, serotonergic and mast cell activation have been identified as potential pathophysiological mechanisms. Additionally, variations in host genes involved in barrier function, antigen presentation and cytokine response have been associated with PI-IBS development. However, it is unknown whether specific pathogens have unique effects on long-term alterations in gut physiology or different pathogens converge to cause common alterations resulting in similar phenotype. The role of microbial virulence and pathogenicity factors in development of PI-IBS is also largely unknown. Additionally, alterations in host gut sensation, motility, secretion, and barrier function in PI-IBS need to be elucidated. Finally, both GI infections and antibiotics used to treat these infections can cause long-term alterations in host commensal microbiota. It is plausible that alteration in the commensal microbiome persists in a subset of patients predisposing them to develop PI-IBS.

AB - Acute infectious gastroenteritis is one of the most commonly identifiable risk factors for the development of irritable bowel syndrome (IBS). A number of bacterial, viral and parasitic pathogens have been found to be associated with the development of IBS and other functional gastrointestinal (GI) disorders. Epidemiological studies have identified demographic and acute enteritis-related risk factors for the development of post-infectious-IBS (PI-IBS). Immune dysregulation, alterations in barrier function, serotonergic and mast cell activation have been identified as potential pathophysiological mechanisms. Additionally, variations in host genes involved in barrier function, antigen presentation and cytokine response have been associated with PI-IBS development. However, it is unknown whether specific pathogens have unique effects on long-term alterations in gut physiology or different pathogens converge to cause common alterations resulting in similar phenotype. The role of microbial virulence and pathogenicity factors in development of PI-IBS is also largely unknown. Additionally, alterations in host gut sensation, motility, secretion, and barrier function in PI-IBS need to be elucidated. Finally, both GI infections and antibiotics used to treat these infections can cause long-term alterations in host commensal microbiota. It is plausible that alteration in the commensal microbiome persists in a subset of patients predisposing them to develop PI-IBS.

KW - Campylobacter jejuni

KW - Functional GI disorders

KW - Infectious gastroenteritis

KW - Post-infectious irritable bowel syndrome

KW - Rritable bowel syndrome

UR - http://www.scopus.com/inward/record.url?scp=84896829195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896829195&partnerID=8YFLogxK

M3 - Review article

VL - 139

SP - 11

EP - 18

JO - Indian Journal of Medical Research

JF - Indian Journal of Medical Research

SN - 0971-5916

ER -